3 ms·

I read today, they’re saying between this and the Pfizer vaccine. They’ll be 40 million doses available this year. Enough for 20 million people. Because we only

I read today, they’re saying between this and the Pfizer vaccine. They’ll be 40 million doses available this year. Enough for 20 million people. Because we only have a month and a half left of this year, when were these vaccines going to come online? And where? Obviously it’ll go to at risk people, but when exactly will it start to roll out if it’s already Nov 15th?

hinkley 6y ago
> Obviously it’ll go to at risk people, The obviousness of this strategy has been challenged over the last 10-20 years. At-risk people in some cases do not respond fully to vaccines, and the reaction can be stressful to their systems. Last I heard, the recommendation for influenza was 100% vaccination for nursing home staff and a strong recommendation for visitors to also get vaccinated. The bubble of protection from this strategy has, apparently, lower overall risks. Doctors and nurses, especially urgent care, will likely be first in line (or perhaps due to an abundance of caution, half of them first in line, half later). I'd like to see the people we have labelled 'essential workers' up next.
35fbe7d3d5b9 6y ago
The rollout of these will likely be fast-tracked by the FDA for an emergency use authorization and rolled out to healthcare providers first. How long, who knows – the fact that this vaccine doesn't require cryogenic cooling like Pfizer's does may be an accelerator.
pradn 6y ago
The National Academies have a set of recommendations for the priority of vaccine distribution. Upshot is that it's going to mainly be high-risk people like healthcare workers and folks with severe risk factors first. https://www.nationalacademies.org/our-work/a-framework-for-equitable-allocation-of-vaccine-for-the-novel-coronavirus https://www.nationalacademies.org/our-work/a-framework-for-e...
- tubularhells 6y ago
  And the rich and the politically connected, of course.
- mchusma 6y ago
  Surprised to see "previously had covid" isn't on the list of criteria. Given that 30%+ of US will have had it by then, makes a big difference in early days of distribution. I do think they should eventually get it but they should be back of the line.
hmmmhmmmhmmm 6y ago
Majority of global doses actually expected to be provided by AstraZeneca. See orders per large country here: https://www.economist.com/graphic-detail/2020/11/13/a-vaccine-against-the-virus https://www.economist.com/graphic-detail/2020/11/13/a-vaccin...

hinkley 6y ago

> Obviously it’ll go to at risk people, The obviousness of this strategy has been challenged over the last 10-20 years. At-risk people in some cases do not respond fully to vaccines, and the reaction can be stressful to their systems. Last I heard, the recommendation for influenza was 100% vaccination for nursing home staff and a strong recommendation for visitors to also get vaccinated. The bubble of protection from this strategy has, apparently, lower overall risks. Doctors and nurses, especially urgent care, will likely be first in line (or perhaps due to an abundance of caution, half of them first in line, half later). I'd like to see the people we have labelled 'essential workers' up next.

35fbe7d3d5b9 6y ago

The rollout of these will likely be fast-tracked by the FDA for an emergency use authorization and rolled out to healthcare providers first. How long, who knows – the fact that this vaccine doesn't require cryogenic cooling like Pfizer's does may be an accelerator.

pradn 6y ago

The National Academies have a set of recommendations for the priority of vaccine distribution. Upshot is that it's going to mainly be high-risk people like healthcare workers and folks with severe risk factors first. https://www.nationalacademies.org/our-work/a-framework-for-equitable-allocation-of-vaccine-for-the-novel-coronavirus https://www.nationalacademies.org/our-work/a-framework-for-e...

tubularhells 6y ago
And the rich and the politically connected, of course.
mchusma 6y ago
Surprised to see "previously had covid" isn't on the list of criteria. Given that 30%+ of US will have had it by then, makes a big difference in early days of distribution. I do think they should eventually get it but they should be back of the line.

hmmmhmmmhmmm 6y ago

Majority of global doses actually expected to be provided by AstraZeneca. See orders per large country here: https://www.economist.com/graphic-detail/2020/11/13/a-vaccine-against-the-virus https://www.economist.com/graphic-detail/2020/11/13/a-vaccin...